Compare NVST & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVST | TWST |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 5.2B |
| IPO Year | 2019 | 2018 |
| Metric | NVST | TWST |
|---|---|---|
| Price | $28.30 | $116.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | $26.46 | ★ $46.88 |
| AVG Volume (30 Days) | ★ 3.0M | 1.4M |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 104.31 | 63.89 |
| EPS | ★ 0.56 | N/A |
| Revenue | ★ $2,566,500,000.00 | $376,572,000.00 |
| Revenue This Year | $6.67 | $18.91 |
| Revenue Next Year | $3.55 | $15.07 |
| P/E Ratio | $48.89 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $18.77 | $23.30 |
| 52 Week High | $30.42 | $115.56 |
| Indicator | NVST | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 53.77 | 63.74 |
| Support Level | $25.49 | $42.88 |
| Resistance Level | $28.43 | N/A |
| Average True Range (ATR) | 0.83 | 8.13 |
| MACD | 0.05 | 1.68 |
| Stochastic Oscillator | 52.51 | 81.47 |
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.